Skip to content

Clinical trials

Phase 3 Stroke trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: United States Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20035
20042
20058
20068
20072
20084
20095
20105
20113
20125
20136
20145
20153
20161
20175
20183
20193
20202
20212
20221
20231
20241
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Terminated21
Recruiting6
Unknown status5
Active, not recruiting3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Columbia University5
Novartis Pharmaceuticals4
Allergan3
National Institute of Neurological Disorders and Stroke (NINDS)3
AstraZeneca2
Boehringer Ingelheim2
Boston Scientific Corporation2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke95
Myocardial Infarction20
Ischemic Stroke17
Atrial Fibrillation15
Cardiovascular Diseases14
Ischemic Attack, Transient9
Heart Diseases7
Thrombosis7
Coronary Artery Disease5
Diabetes Mellitus5

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.